LY2874455 2 mg | Purity Not Available
TargetMol
LY2874455 has been used in trials studying the treatment of Advanced Cancer.
More Information Supplier PageLY2874455
Search Results
PTC-209 100 mg | 99.52%
TargetMol
PTC-209
AC1NS4RE 100 mg | 99.53%
TargetMol
AC1NS4RE
Indacaterol 25 mg | 100.00%
TargetMol
Indacaterol (Onbrez; Arcapta) is a β2-Adrenergic Agonist. The mechanism of action of indacaterol is as an Adrenergic beta2-Agonist.
More Information Supplier PageIndacaterol
Brexpiprazole 25 mg | 99.69%
TargetMol
Brexpiprazole is a partial agonist of human 5-hydroxytryptamine (5-HT) 5-HT1A and dopamine D2 receptors.
More Information Supplier PageBrexpiprazole
SP2509 25 mg | 99.49%
TargetMol
SP2509 is a specific histone demethylase LSD1 inhibitor(IC50 =13 nM).
More Information Supplier PageSP2509
BMS-833923 200 mg | 99.61%
TargetMol
BMS-833923, an orally bioavailable Smoothened antagonist, inhibits BODIPY cyclopamine binding to SMO in a dose-dependent manner (IC50: 21 nM).
More Information Supplier PageBMS-833923
LY2874455 25 mg | Purity Not Available
TargetMol
LY2874455 has been used in trials studying the treatment of Advanced Cancer.
More Information Supplier PageLY2874455
Camostat mesylate 25 mg | 99.69%
TargetMol
Camostat is a trypsin-like protease inhibitor and inhibits airway epithelial sodium channel (ENaC) function.
More Information Supplier PageCamostat mesylate
INH1 100 mg | Purity Not Available
TargetMol
INH1 is a cell-permeable Hec1 inhibitor that specifically disrupts the Hec1/Nek2 interaction.
More Information Supplier PageINH1
